We are live on ! Find out more
TROVW

TrovaGene, Inc. Warrant
TROVW

Delisted

TROVW was delisted on the 30th of May, 2017.

Back to rankings

4 hedge funds and large institutions have $1.18M invested in TrovaGene, Inc. Warrant in 2016 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

149% more call options, than puts

Call options by funds: $172K | Put options by funds: $69K

0% more funds holding

Funds holding: 4 → 4 (0)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

43% less capital invested

Capital invested by funds: $2.06M → $1.18M (-$876K)

Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
–
Calls
$172K
Puts
$69K
Net Calls
+$103K
Net Calls Change
+$116K

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$2.21K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$7.06K
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
1
Millennium Management
New York
$1.17M -$7.06K -2,300 -0.5%
Morgan Stanley
2
Morgan Stanley
New York
$8K – – –
UBS Group
3
UBS Group
Switzerland
$2K +$2.21K +720 +720%
TRCT
4
Tower Research Capital (TRC)
New York
$1K – – –

TROVW Hedge Fund Activity: Q2 2016 in Review

4 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in TrovaGene, Inc. Warrant (TROVW) for Q2 2016, worth a combined $1.18M — down 43% from $2.06M a quarter earlier.

Fund positioning in TROVW was balanced in Q2 2016: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.

The largest buyer was UBS Group, adding an estimated $2.21K. The largest seller was Millennium Management, cutting an estimated $7.06K.

  • 4 institutional investors held TrovaGene, Inc. Warrant (TROVW) as of Q2 2016, unchanged from Q1 2016.
  • Funds reported $1.18M of TrovaGene, Inc. Warrant stock for Q2 2016, down 43% quarter-over-quarter.
  • 0 funds opened new TrovaGene, Inc. Warrant positions in Q2 2016 and 0 closed out.
  • The largest TrovaGene, Inc. Warrant buyer in Q2 2016 was UBS Group, an estimated $2.21K added.
  • The largest TrovaGene, Inc. Warrant seller in Q2 2016 was Millennium Management, an estimated $7.06K sold.

Based on aggregated 13F filings for Q2 2016.